1. |
Fan P, Zhang D, Pan XC, et al. Premature stroke secondary to severe hypertension results from liddle syndrome caused by a novel SCNN1B mutation. Kidney Blood Press Res, 2020, 45(4): 603-611.
|
2. |
Enslow BT, Stockand JD, Berman JM. Liddle's syndrome mechanisms, diagnosis and management. Integr Blood Press Control, 2019, 12: 13-22.
|
3. |
Liddle G, Bledsoe T, Coppage W. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Phys, 1963, 76: 199-213.
|
4. |
Kozina AA, Trofimova TA, Okuneva EG, et al. Liddle syndrome due to a novel mutation in the γ subunit of the epithelial sodium channel (ENaC) in family from Russia: A case report. BMC Nephrol, 2019, 20(1): 389.
|
5. |
蒋晖. Liddle 综合征研究进展. 心血管病学进展, 2018, 39(2): 263-266.
|
6. |
梁致如, 高凌根, 范利. Liddle 综合征研究进展. 中华老年多器官疾病杂志, 2016, 15(5): 387-391.
|
7. |
Epstein M, Calhoun DA. Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. J Clin Hypertens (Greenwich), 2011, 13(9): 644-648.
|
8. |
Awadalla M, Patwardhan M, Alsamsam A, et al. Management of Liddle syndrome in pregnancy: A case report and literature review. Case Rep Obstet Gynecol, 2017, 2017: 6279460.
|
9. |
Caretto A, Primerano L, Novara F, et al. A therapeutic challenge: Liddle's syndrome managed with amiloride during pregnancy. Case Rep Obstet Gynecol, 2014, 2014: 156250.
|
10. |
Fan P, Lu CX, Yang KQ, et al. Truncated epithelial sodium channel β subunit responsible for Liddle syndrome in a Chinese family. Kidney Blood Press Res, 2019, 44(5): 942-949.
|
11. |
李玲, 刘敏. 病例 213: 57 岁女性高血压伴反复低血钾症. 中华高血压杂志, 2020, 28(2): 187-190.
|
12. |
Warnock DG. Liddle syndrome: An autosomal dominant form of human hypertension. Kidney Int, 1998, 53(1): 18-24.
|
13. |
Yang KQ, Lu CX, Fan P, et al. Genetic screening of SCNN1B and SCNN1G genes in early-onset hypertensive patients helps to identify Liddle syndrome. Clin Exp Hypertens, 2018, 40(2): 107-111.
|
14. |
Wan HH, Lye MD. Moduretic-induced metabolic acidosis and hyperkalaemia. Postgrad Med J, 1980, 56(655): 348-350.
|
15. |
Blumenberg D. Triamterene. Krankenpfl J, 1990, 28(4): 166-167.
|
16. |
Paver WK, Pauline GJ. Hypertension and hyperpotassaemia without renal disease in a young male. Med J Aust, 1964, 2: 305-306.
|
17. |
Mabillard H, Sayer JA. The molecular genetics of Gordon syndrome. Genes, 2019, 10(12): 2073-4425.
|
18. |
Loffing J. The thiazide-sensitive NaCl cotransporter. Nieren- und Hochdruckkrankheiten, 2016, 45(6): 247-251.
|
19. |
Boyden LM, Choi M, Choate KA, et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature, 2012, 482(7383): 98-102.
|
20. |
O'Shaughnessy KM. Gordon syndrome: A continuing story. Pediatr Nephrol, 2015, 30(11): 1903-1908.
|
21. |
Yang Y, Ou Y, Ren Y, et al. Hypertension accompanied by hyperaldosteronism, hyperkalemia, and hyperchloremic acidosis: A case report and literature Review. Case Rep Endocrinol, 2020, 2020: 1-6.
|
22. |
Golbang AP, Murthy M, Hamad A, et al. A new kindred with pseudohypoaldosteronism type Ⅱ and a novel mutation (564D>H) in the acidic motif of the WNK4 gene. Hypertension, 2005, 46(2): 295-300.
|
23. |
Roy S. Hydrochlorothiazide. AMA J Ethics, 2017, 19(9): 947-948.
|